Suchergebnisse

The consensus conference was supported by Wellcome Genome Campus Advanced Courses and Scientific Conferences. C.C.M. is supported in part by US NIH grants P01 CA91955, R01 CA149566, R01 CA170595, R01 CA185138 and R01 CA140657 as well as CDMRP Breast Cancer Research Program Award BC132057. M.J. is supported by NIH grant K99CA201606. K.S.A. is supported by NCI 5R21 CA196460. K. Polyak is supported by R35 CA197623, U01 CA195469, U54 CA193461, and the Breast Cancer Research Foundation. K.J.P. is supported by NIH grants CA143803, CA163124, CA093900 and CA143055. D.P. is supported by the European Research Council (ERC-617457- PHYLOCANCER), the Spanish Ministry of Economy and Competitiveness (BFU2015-63774-P) and the Education, Culture and University Development Department of the Galician Government. K.S.A. is supported in part by the Breast Cancer Research Foundation and NCI R21CA196460. C.S. is supported by the Royal Society, Cancer Research UK (FC001169), the UK Medical Research Council (FC001169), and the Wellcome Trust (FC001169), NovoNordisk Foundation (ID 16584), the Breast Cancer Research Foundation (BCRF), the European Research Council (THESEUS) and Marie Curie Network PloidyNet. T.A.G. is a Cancer Research UK fellow and a Wellcome Trust funded Investigator. E.S.H. is supported by R01 CA185138-01 and W81XWH-14-1-0473. M.Gerlinger is supported by Cancer Research UK and The Royal Marsden/ICR National Institute of Health Research Biomedical Research Centre. M.Ge., M.Gr., Y.Y., and A.So. were also supported in part by the Wellcome Trust [105104/Z/14/Z]. J.D.S. holds the Edward B. Clark, MD Chair in Pediatric Research, and is supported by the Primary Children's Hospital (PCH) Pediatric Cancer Research Program, funded by the Intermountain Healthcare Foundation and the PCH Foundation. A.S. is supported by the Chris Rokos Fellowship in Evolution and Cancer. Y.Y. is a Cancer Research UK fellow and supported by The Royal Marsden/ICR National Institute of Health Research Biomedical Research Centre. E.S.H. was supported in part by PCORI grants 1505–30497 and 1503–29572, NIH grants R01 CA185138, T32 CA093245, and U10 CA180857, CDMRP Breast Cancer Research Program Award BC132057, a CRUK Grand Challenge grant, and the Breast Cancer Research Foundation. A.R.A.A. was funded in part by NIH grant U01CA151924. A.R.A.A., R.G. and J.S.B. were funded in part by NIH grant U54CA193489.

Funding for this study was provided by: CancerResearch UK (C6199/A10417 and C399/A2291),the European Union Seventh Framework Programme(FP7/207-2013) grant 258236 collaborative projectSYSCOL, European Research Council project EVO-CAN, the Dutch Cancer Society, Research FundFlanders (F.W.O.) grant no. G.0827.13, the MedicalResearch Council, the Wellcome Trust and Departmentof Health as part of a Health Innovation ChallengeFund grant (R6-388), the National Institute for HealthResearch (NIHR) Oxford Biomedical Research Cen-tre, Ovarian Cancer Action and core funding to theWellcome Trust Centre for Human Genetics from theWellcome Trust (090532/Z/09/Z). The views expressedare those of the authors and not necessarily those ofthe NHS, the NIHR, the Department of Health or theWellcome Trust.DT is funded by an EPSRC doctoral training grantvia CoMPLEX. MG is funded by a Studentshipfrom the Wellcome Trust. TB is funded by theDutch Cancer Society Young Investigator Grant10418. ADB acknowledges funding from the Well-come Trust (102732/Z/13/Z), Cancer Research UK(C31641/A23923) and the Medical Research Coun-cil (MR/M016587/1). FA is a senior researcher forthe F.W.O. TG is a Cancer Research UK CareerDevelopment Fellow (A19771) and a Wellcome TrustInvestigator (202778/Z/16/Z). DNC is funded by aHealth Foundation/Academy of Medical SciencesClinician Scientist Fellowship.The cost of open access publication was provided bycore funding to the Wellcome Trust Centre for HumanGenetics from the Wellcome Trust (090532/Z/09/Z).